196 related articles for article (PubMed ID: 7728128)
21. Effect of prophylaxis on fungal infection and costs for high-risk liver transplant recipients.
Reed A; Herndon JB; Ersoz N; Fujikawa T; Schain D; Lipori P; Hemming A; Li Q; Shenkman E; Vogel B
Liver Transpl; 2007 Dec; 13(12):1743-50. PubMed ID: 18044769
[TBL] [Abstract][Full Text] [Related]
22. Infection prophylaxis in the patient with bone marrow failure.
Hann IM; Prentice HG
Clin Haematol; 1984 Oct; 13(3):523-47. PubMed ID: 6437716
[TBL] [Abstract][Full Text] [Related]
23. Antifungal prophylaxis among allogeneic hematopoietic stem cell transplant recipients: current issues and new agents.
Strasfeld L; Weinstock DM
Expert Rev Anti Infect Ther; 2006 Jun; 4(3):457-68. PubMed ID: 16771622
[TBL] [Abstract][Full Text] [Related]
24. Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients.
Winston DJ; Ho WG; Bartoni K; Champlin RE
Bone Marrow Transplant; 1993 Sep; 12(3):283-8. PubMed ID: 8241988
[TBL] [Abstract][Full Text] [Related]
25. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
[TBL] [Abstract][Full Text] [Related]
26. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
Trenschel R; Peceny R; Runde V; Elmaagacli A; Dermoumi H; Heintschel von Heinegg E; Müller KD; Schaefer UW; Beelen DW
Bone Marrow Transplant; 2000 Nov; 26(9):993-7. PubMed ID: 11100279
[TBL] [Abstract][Full Text] [Related]
27. [Prevention of infection in recipients of solid organ transplants].
Lumbreras C; Otero JR; Aguado JM
Enferm Infecc Microbiol Clin; 1997 May; 15 Suppl 2():77-89. PubMed ID: 9312302
[No Abstract] [Full Text] [Related]
28. [Prevention of bacterial and fungal infections in neutropenic patients with malignant hematologic diseases].
Candoni A; Russo D; Salmaso F
Clin Ter; 1997; 148(1-2):23-8. PubMed ID: 9377834
[TBL] [Abstract][Full Text] [Related]
29. Infections in allogeneic bone marrow transplant recipients.
Wingard JR
Semin Oncol; 1993 Oct; 20(5 Suppl 6):80-7. PubMed ID: 8211220
[TBL] [Abstract][Full Text] [Related]
30. Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients.
Tollemar J; Ringdén O; Andersson S; Sundberg B; Ljungman P; Tydén G
Bone Marrow Transplant; 1993 Dec; 12(6):577-82. PubMed ID: 8136741
[TBL] [Abstract][Full Text] [Related]
31. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.
Rex JH; Walsh TJ; Sobel JD; Filler SG; Pappas PG; Dismukes WE; Edwards JE
Clin Infect Dis; 2000 Apr; 30(4):662-78. PubMed ID: 10770728
[TBL] [Abstract][Full Text] [Related]
32. Postoperative bacterial/fungal infections: a challenging problem in critically ill patients after abdominal surgery.
Lichtenstern C; Schmidt J; Knaebel HP; Martin E; Büchler MW; Weigand MA
Dig Surg; 2007; 24(1):1-11. PubMed ID: 17259712
[TBL] [Abstract][Full Text] [Related]
33. Preface. Infections in the intensive care unit.
Kollef MH; Micek ST
Infect Dis Clin North Am; 2009 Sep; 23(3):xiii-xiv. PubMed ID: 19665077
[No Abstract] [Full Text] [Related]
34. Prevention of infections in bone marrow transplant recipients.
Serody JS; Shea TC
Infect Dis Clin North Am; 1997 Jun; 11(2):459-77. PubMed ID: 9187956
[TBL] [Abstract][Full Text] [Related]
35. [Azole antifungal agents in the prevention of fungal infections in neutropenic patients and bone marrow graft recipients].
Lortholary O; Dupont B
Ann Med Interne (Paris); 1997; 148(3):258-67. PubMed ID: 9255336
[TBL] [Abstract][Full Text] [Related]
36. [Antiinfectious prophylaxis in pediatric oncology. Work group "Quality Assurance" of Society for Pediatric Oncology and Hematology (GPOH)].
Graubner UB; Boos J; Creutzig U; Dörffel W; Lakomek M; Niemeyer C; Schrappe M; Spaar HJ; Belohradsky BH
Klin Padiatr; 1999; 211(4):347-52. PubMed ID: 10472574
[TBL] [Abstract][Full Text] [Related]
37. Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years.
Hovi L; Saarinen-Pihkala UM; Vettenranta K; Saxen H
Bone Marrow Transplant; 2000 Nov; 26(9):999-1004. PubMed ID: 11100280
[TBL] [Abstract][Full Text] [Related]
38. [Infection prevention in the patient undergoing hematopoietic stem cell transplantation].
Baro J; Richard C; Zubizarreta A
Enferm Infecc Microbiol Clin; 1997 May; 15 Suppl 2():90-7. PubMed ID: 9312303
[No Abstract] [Full Text] [Related]
39. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
[TBL] [Abstract][Full Text] [Related]
40. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
Carlens S; Ringdén O; Aschan J; Hägglund H; Ljungman P; Mattsson J; Remberger M
Clin Transplant; 1998 Apr; 12(2):84-92. PubMed ID: 9575394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
